Press Room

Event

IRDD 2021 - The BioTech Pharma Summit

Start
Monday, November 29, 2021 - 00:00
End
Tuesday, November 30, 2021 - 00:00
Location: Porto, Portugal
BioTech Pharma Summit Hovione is present with a Drug Product Development Scientist | Hovione

Hovione is present at the BioTech Pharma Summit taking place in Oporto, Portugal. Our expert in drug product develpment will present on day 1 in the Inhalation & Respiratory Drug Delivery stream. Join us.

 

Hovione Presentation

Day 1 - Monday, November 29th 2021 | 11:30 - 12:00

Stream: Inhalation & Respiratory Drug Delivery

Session: Inhalation Formulation Solutions & Technology

 

High Dosage DPI – formulation and process development considerations

Presenter: Beatriz Noriega Fernandes, Scientist, Formulation Group - Drug Product Development at Hovione



Abstract: 

Biopharmaceuticals represent the most promising and fastest growing field in the pharmaceutical area. These therapeutics show very high specificity and potency at relatively low concentrations and enable the treatment of otherwise untreatable diseases. One of the main challenges when developing a spray dried biopharmaceutical formulation for Dry Powder Inhalers is the generation of a stable aerosol able to reach the lungs while preserving the integrity of the biopharmaceutical, rendering it safe and effective. In this presentation the most promising alternatives to freeze drying with focus on particle engineering methods for dry powder inhalation such as spray drying will be discussed. Case-studies will be provided to support participants diving into specific examples of selected topics.

The presentation will provide participants the opportunity to learn about the integration of technologies and capabilities to take a Dry Powder Inhalation product development from early-stage development to commercial stage products.

 

 

Hovione present at the BioTech Pharma Conference | Hovione Virtual Stand
https://www.biotechpharmasummit.com/



 

If you would like to discuss with us your projects and to find how Hovione can help, schedule a meeting with us. Our team will be pleased to meet you.



 

Schedule a meeting button | Hovione
https://go.hovione.com/l/47122/2014-08-06/9grc



 



 

You might be interested in:









 

Also in the Press Room

See All

Every year, the largest bank in Portugal, Caixa Geral de Depósitos recognizes some of Portugal’s brightest young minds through the Caixa +Mundo Awards, providing nearly €800,000 in scholarships to students as they pursue higher education. In this year´s edition, Caixa named the award bestowed upon students pursuing science for Diane Villax. This prestigious honor places Diane Villax among the award’s namesakes – a distinguished group of prominent personalities who have made notable contributions to Portugal´s socio-economic, cultural, political and scientific development over the last 50 years, such as António Ramalho Eanes, Mário Soares, José Saramago, Sophia de Mello Breyner, Leonor Beleza, Elvira Fortunato, Rui Nabeiro, Américo Amorim, and José Manuel de Mello. Diane Villax will also honor the seven scientific award winners by personally meeting with each of them, and following their journeys as future innovators and leaders. But this honor is about far more than one individual. It is a celebration of an entire organization and the people behind it. For 67 years, generations of dedicated teams have worked together with passion, purpose, and excellence to manufacture life-saving medicines and advance science that has a real impact on people. This recognition belongs to all of us.    

News

Prestigious Caixa +Mundo Award named in honor of Diane Villax

May 14, 2026

CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing services. The companies partnered in 2023 with plans for development of two capsule-based devices for intranasal delivery: the single-use device and a multidose device. Read the full article at OINDPnews.com      

Press Clipping
OINDP - Orally inhaled and nasal drug products news, May 11, 2026

Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations

May 11, 2026

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping
Contract Pharma, 7 May 2026

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026

Also in Events

See All